新华医疗子公司拟出售华检医疗不超5%股份

Core Viewpoint - Xinhua Medical (600587.SH) announced its plan to sell up to 5% of its subsidiary Huajian Medical Holdings Co., Ltd. through public market transactions to focus on its core business and enhance asset operation efficiency [1] Group 1 - The company aims to improve operational efficiency by divesting a portion of its stake in Huajian Medical [1] - The sale will be conducted through public market transactions, indicating a strategic move to optimize asset management [1] - This decision reflects the company's commitment to concentrating on its primary business activities [1]